Hiscox's increased Covid-19 loss estimate and its resilience in the face of a potentially adverse decision in the FCA BI process took most of the headlines as it reported yesterday.
But
Hiscox's increased Covid-19 loss estimate and its resilience in the face of a potentially adverse decision in the FCA BI process took most of the headlines as it reported yesterday.
But